|
Liu, Ganqiang; Locascio, Joseph J; Corvol, Jean-Christophe et al. (2017) Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol 16:620-629
|
|
Liu, Ganqiang; Boot, Brendon; Locascio, Joseph J et al. (2016) Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. Ann Neurol 80:674-685
|
|
DeMarshall, Cassandra A; Han, Min; Nagele, Eric P et al. (2015) Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease. Immunol Lett 168:80-8
|
|
Pankratz, Nathan; Beecham, Gary W; DeStefano, Anita L et al. (2012) Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol 71:370-84
|
|
Marras, Connie; McDermott, Michael P; Marek, Ken et al. (2011) Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts. Mov Disord 26:608-13
|
|
Evatt, Marian L; DeLong, Mahlon R; Kumari, Meena et al. (2011) High prevalence of hypovitaminosis D status in patients with early Parkinson disease. Arch Neurol 68:314-9
|
|
Shoulson, Ira (2010) Therapeutic directions for Parkinson's disease. Mov Disord 25 Suppl 1:S152-4
|
|
Ascherio, Alberto; LeWitt, Peter A; Xu, Kui et al. (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460-8
|
|
Marras, Connie; Lang, Anthony E; Eberly, Shirley W et al. (2009) A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts. Mov Disord 24:2370-8
|
|
Marras, Connie; McDermott, Michael P; Rochon, Paula A et al. (2008) Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord 23:653-9;quiz 776
|
Showing the most recent 10 out of 46 publications
